Haematology 2018

Eligibility and treatment schema

Eligibility Disease: rel/ref HL Stage: early/early (dx/relapse) Tx: <6c chemotherapy RT: none or relapse out of field Pembrolizumab 200 mg q3w x4 PET-Sim PET-Sim

Exclusion : Advanced stage (dx or relapse Tx: 6c chemotherapy In-field relapse B symptoms or bulky disease

DS 4-5 w/o new sites Responding on CT

DS 1-3

New lesions POD on CT

(within 14-21d)

ISRT

30 Gy

Biopsy

Off Study

4-6w

Pos

Neg

EOT PET

30 Gy

36-40 Gy